Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters appied:
Tag
close icon
Sort by
SHOCK INDEX IN THE EARLY ASSESSMENT OF FEBRILE CHILDREN AT THE EMERGENCY
Hagedoorn NN, Zachariasse JM, Borensztajn D, Adriaansens E, von Both U, Carrol ED, Eleftheriou I, Emonts M, van der Flier M, de Groot R, Herberg JA, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, Zavadska D, Zenz W, Levin M, Vermont C, Moll HA; PERFORM consortium
Journal:
Arch Dis Child
Publicación independiente
Impact factor
3.801
Q1
Year:
2022
Doi:
https://doi.org/10.1136/archdischild-2020-320992
NIRSEVIMAB FOR PREVENTION OF RSV IN HEALTHY LATE-PRETERM AND TERM INFANTS
Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, Wählby Hamrén U, Mankad VS, Ren P, Takas T, Abram ME, Leach A, Griffin MP, Villafana T; MELODY Study Group (Martinón-Torres F)
Journal:
N Engl J Med
Publicación independiente
Impact factor
91.253
Q1
Year:
2022
Doi:
VESICULOBULLOUS SKIN REACTIONS INDUCED BY COVID-19 MRNA VACCINE: REPORT OF FOUR CASES AND REVIEW OF THE LITERATURE
Coto-Segura P, Fernández-Prada M, Mir-Bonafé M, García-García B, González-Iglesias I, Alonso-Penanes P, González-Guerrero M, Gutiérrez-Palacios A, Miranda-Martínez E, Martinón-Torres F
Journal:
Clin Exp Dermatol
Publicación independiente
Impact factor
3.470
Q2
Year:
2022
Doi:
https://doi.org/10.1111/ced.14835
EVALUATION OF THE BNT162B2 COVID-19 VACCINE IN CHILDREN 5 TO 11 YEARS OF AGE
Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Muñoz FM, Maldonado Y, Pahud BA, Domachowske JB, Simões EAF, Sarwar UN, Kitchin N, Cunliffe L, Rojo P, Kuchar E, Rämet M, Munjal I, Perez JL, Frenck RW Jr, Lagkadinou E, Swanson KA, Ma H, Xu X, Koury K, Mather S, Belanger TJ, Cooper D, Türeci Ö, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591007 Clinical Trial Group. (Martinón-Torres F)
Journal:
N Engl J Med
Publicación independiente
Impact factor
91.253
Q1
Year:
2022
Doi:
CORRIGENDUM: CASE REPORT: TWO MONOCHORIONIC TWINS WITH A CRITICALLY DIFFERENT COURSE OF PROGRESSIVE OSSEOUS HETEROPLASIA
Justicia-Grande AJ, Gómez-Ríal J, Rivero-Calle I, Pischedda S, Curras-Tuala MJ, Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Méndez-Gallart R, Fernández-Seara MJ, Salas A, Martinón-Torres F
Journal:
Front Pediatr
Publicación independiente
Impact factor
3.418
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fped.2021.807812
EARLY IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ON PEDIATRIC CLINICAL RESEARCH: A PAN-EUROPEAN AND CANADIAN SNAPSHOT IN TIME.
Mantha OL, Flamein F, Turner MA, Fernandes RM, Hankard R; Network of National Networks Study Group. (Martinón-Torres F)
Journal:
J Pediatr
Publicación independiente
Impact factor
4.406
Q1
Year:
2021
Doi:
DETECTABLE A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS-1 IN SERUM IS ASSOCIATED WITH ADVERSE OUTCOME IN PEDIATRIC SEPSIS
Boeddha NP, Driessen GJ, Hagedoorn NN, Kohlfuerst DS, Hoggart CJ, van Rijswijk AL, Ekinci E, Priem D, Schlapbach LJ, Herberg JA, de Groot R, Anderson ST, Fink CG, Carrol ED, van der Flier M, Martinón-Torres F, Levin M, Leebeek FW, Zenz W, de Maat MPM, Hazelzet JA, Emonts M, Dik WA.
Journal:
Crit Care Explor
Publicación independiente
Impact factor
9.907
Q1
Year:
2021
Doi:
https://doi.org/10.1097/CCE.0000000000000569
EDITORIAL: VACCINATION OF SPECIAL POPULATIONS: PROTECTING THE VULNERABLE.
O'Connor D, Moschese V, Martinon-Torres F, Palma P.
Journal:
Front Immunol
Publicación independiente
Impact factor
7.561
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fimmu.2021.815550
WORLD HEALTH ORGANIZATION INFLUENZA-LIKE ILLNESS UNDERESTIMATES THE BURDEN OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN COMMUNITY-DWELLING OLDER ADULTS.
Korsten K, Adriaenssens N, Coenen S, Butler CC, Verheij TJM, Bont LJ, Wildenbeest JG; RESCEU Investigators.(Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
TIPICO XI: REPORT OF THE FIRST SERIES AND PODCAST ON INFECTIOUS DISEASES AND VACCINES (ATIPICO)
Martinón-Torres F, García-Sastre A, Pollard AJ, Martín C, Osterhaus A, Ladhani SN, Ramilo O, Gómez Rial J, Salas A, Bosch FX, Martinón-Torres M, Mina MJ, Cherry J
Journal:
Hum Vaccin Immunother
Publicación independiente
Impact factor
3.452
Q2
Year:
2021
Doi:
https://doi.org/10.1080/21645515.2021.1953351
SUPPORTING NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUPS IN THE WHO EUROPEAN REGION IN DEVELOPING NATIONAL COVID-19 VACCINATION RECOMMENDATIONS THROUGH ONLINE COMMUNICATION PLATFORM
Mosina L, Külper-Schiek W, Jacques-Carroll L, Earnshaw A, Harder T, Martinón-Torres F, Wilder-Smith A, Wichmann O, Datta SS
Journal:
Vaccine
Publicación independiente
Impact factor
3.641
Q3
Year:
2021
Doi:
https://doi.org/10.1016/j.vaccine.2021.09.034
EXPLORATORY ANALYSIS OF THE ECONOMICALLY JUSTIFIABLE PRICE OF A HYPOTHETICAL RSV VACCINE FOR OLDER ADULTS IN THE NETHERLANDS AND THE UNITED KINGDOM
Zeevat F, Luttjeboer J, Paulissen JHJ, van der Schans J, Beutels P, Boersma C, Postma MJ; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
A SYSTEMATIC REVIEW AND META-ANALYSIS OF ANIMAL STUDIES INVESTIGATING THE RELATIONSHIP BETWEEN SERUM ANTIBODY, T LYMPHOCYTES, AND RESPIRATORY SYNCYTIAL VIRUS DISEASE
McGinley J, Thwaites R, Brebner W, Greenan-Barrett L, Aerssens J, Öner D, Bont L, Wildenbeest J, Martinón-Torres F, Nair H, Pollard AJ, Openshaw P, Drysdale S; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
https://doi.org/10.1093/infdis/jiab370
PUBLISHER CORRECTION: DISTINCT PATTERNS OF WITHIN-HOST VIRUS POPULATIONS BETWEEN TWO SUBGROUPS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
Lin GL, Drysdale SB, Snape MD, O'Connor D, Brown A, MacIntyre-Cockett G, Mellado-Gomez E, de Cesare M, Bonsall D, Ansari MA, Öner D, Aerssens J, Butler C, Bont L, Openshaw P, Martinón-Torres F, Nair H, Bowden R; RESCEU Investigators, Golubchik T, Pollard AJ
Journal:
Nat Commun
Publicación independiente
Impact factor
14.919
Q1
Year:
2021
Doi:
https://doi.org/10.1038/s41467-021-26291-y
DISEASE BURDEN ESTIMATES OF RESPIRATORY SYNCYTIAL VIRUS RELATED ACUTE RESPIRATORY INFECTIONS IN ADULTS WITH COMORBIDITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Shi T, Vennard S, Jasiewicz F, Brogden R, Nair H; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
SUPERSPREADING IN THE EMERGENCE OF COVID-19 VARIANTS
Gómez-Carballa A, Pardo-Seco J, Bello X, Martinón-Torres F, Salas A
Journal:
Trends Genet
Publicación independiente
Impact factor
11.639
Q1
Year:
2021
Doi:
https://doi.org/10.1016/j.tig.2021.09.003
A NOVEL VACCINE TO PREVENT MENINGOCOCCAL DISEASE BEYOND THE FIRST YEAR OF LIFE: AN EARLY REVIEW OF MENACYW-TT
Martinón-Torres F, Bertrand-Gerentes I, Oster P
Journal:
Expert Rev Vaccines
Publicación independiente
Impact factor
5.217
Q2
Year:
2021
Doi:
https://doi.org/10.1080/14760584.2021.1964962
A NICE COMBINATION FOR PREDICTING HOSPITALISATION AT THE EMERGENCY DEPARTMENT: A EUROPEAN MULTICENTRE OBSERVATIONAL STUDY OF FEBRILE CHILDREN
Borensztajn DM, Hagedoorn NN, Carrol ED, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Lim E, Maconochie IK, Martinon-Torres F, Nieboer D, Nijman RG, Oostenbrink R, Pokorn M, Calle IR, Strle F, Tsolia M, Vermont CL, Yeung S, Zavadska D, Zenz W, Levin M, Moll HA; PERFORM consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union
Journal:
Lancet Reg Health Eur
Publicación independiente
Impact factor
19.173
Q1
Year:
2021
Doi:
https://doi.org/10.1016/j.lanepe.2021.100173
SENSOGENOMICS AND THE BIOLOGICAL BACKGROUND UNDERLYING MUSICAL STIMULI: PERSPECTIVES FOR A NEW ERA OF MUSICAL RESEARCH
Navarro L, Martinón-Torres F, Salas A
Journal:
Genes (Basel)
Publicación independiente
Impact factor
4.096
Q2
Year:
2021
Doi:
https://doi.org/10.3390/genes12091454
DISTINCT PATTERNS OF WITHIN-HOST VIRUS POPULATIONS BETWEEN TWO SUBGROUPS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
Lin GL, Drysdale SB, Snape MD, O'Connor D, Brown A, MacIntyre-Cockett G, Mellado-Gomez E, de Cesare M, Bonsall D, Ansari MA, Öner D, Aerssens J, Butler C, Bont L, Openshaw P, Martinón-Torres F, Nair H, Bowden R; RESCEU Investigators, Golubchik T, Pollard AJ
Journal:
Nat Commun
Publicación independiente
Impact factor
14.919
Q1
Year:
2021
Doi:
https://doi.org/10.1038/s41467-021-25265-4
COADMINISTRATION OF ANTI-VIRAL MONOCLONAL ANTIBODIES WITH ROUTINE PEDIATRIC VACCINES AND IMPLICATIONS FOR NIRSEVIMAB USE: A WHITE PAPER
Esposito S, Abu-Raya B, Bonanni P, Cahn-Sellem F, Flanagan KL, Martinon Torres F, Mejias A, Nadel S, Safadi MAP, Simon A
Journal:
Front Immunol
Publicación independiente
Impact factor
7.561
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fimmu.2021.708939
AETIOLOGY OF ACUTE RESPIRATORY INFECTION IN PRESCHOOL CHILDREN REQUIRING HOSPITALISATION IN EUROPE-RESULTS FROM THE PED-MERMAIDS MULTICENTRE CASE-CONTROL STUDY
Kohns Vasconcelos M, Loens K, Sigfrid L, Iosifidis E, Epalza C, Donà D, Matheeussen V, Papachristou S, Roilides E, Gijon M, Rojo P, Minotti C, Da Dalt L, Islam S, Jarvis J, Syggelou A, Tsolia M, Nyirenda Nyang'wa M, Keers S, Renk H, Gemmel AL, D'Amore C, Ciofi Degli Atti M, Rodríguez-Tenreiro Sánchez C, Martinón-Torres F, Burokienė S, Goetghebuer T, Spoulou V, Riordan A, Calvo C, Gkentzi D, Hufnagel M, Openshaw PJ, de Jong MD, Koopmans M, Goossens H, Ieven M, Fraaij PLA, Giaquinto C, Bielicki JA, Horby P, Sharland M.
Journal:
BMJ Open Respir Res
Publicación independiente
Impact factor
2.692
Q2
Year:
2021
Doi:
https://doi.org/10.1136/bmjresp-2021-000887
A NOVEL FRAMEWORK FOR PHENOTYPING CHILDREN WITH SUSPECTED OR CONFIRMED INFECTION FOR FUTURE BIOMARKER STUDIES
Nijman RG, Oostenbrink R, Moll HA, Casals-Pascual C, von Both U, Cunnington A, De T, Eleftheriou I, Emonts M, Fink C, van der Flier M, de Groot R, Kaforou M, Kohlmaier B, Kuijpers TW, Lim E, Maconochie IK, Paulus S, Martinon-Torres F, Pokorn M, Romaine ST, Calle IR, Schlapbach LJ, Smit FJ, Tsolia M, Usuf E, Wright VJ, Yeung S, Zavadska D, Zenz W, Levin M, Herberg JA, Carrol ED; PERFORM consortium (Personalized Risk assessment in febrile children to optimize Real-life Management across the European Union).
Journal:
Front Pediatr
Publicación independiente
Impact factor
3.418
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fped.2021.688272
EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF M-M-RII (COMBINATION MEASLES-MUMPS-RUBELLA VACCINE): CLINICAL TRIALS OF HEALTHY CHILDREN AND ADULTS PUBLISHED BETWEEN 2010 AND 2019
Nyaku M, Richardson E, Martinon-Torres F, Kuter BJ
Journal:
Pediatr Infect Dis J
Publicación independiente
Impact factor
2.129
Q3
Year:
2021
Doi:
https://doi.org/10.1097/INF.0000000000003273
No results found.
13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants.
Federico Martinón-Torres, Hanna Czajka, Kimberly J. Center, Jacek Wysocki, Ewa Majda-Stanislawska, Felix Omeñaca, Enrique Bernaola Iturbe, Daniel Blazquez Gamero, Ana Concheiro-Guisán, Francisco Gimenez-Sanchez, Leszek Szenborn, Peter C. Giardina, Scott Patterson, William C. Gruber, Daniel A. Scott, Alejandra Gurtman
Doi:
Pediatrics
Factor de impacto:
Q1
Doi:
Vaccine evaluation: lessons from a meningococcal B vaccine.
Sarfatti A, Martinón-Torres F, Nadel S
Doi:
Arch Dis Child
Factor de impacto:
Q1
Doi:
Should the Indication of Pneumococcal Polysaccharide Vaccine in Children Be Definitively Withdrawn?
Federico Martinón Torres
Doi:
Clin Infect Dis
Factor de impacto:
Q1
Doi:
Rotavirus vaccination in Europe: drivers and barriers.
N Parez, C Giaquinto, C Du Roure, F Martinon-Torres, V Spoulou, P Van Damme, T Vesikari
Doi:
Lancet Infect Dis
Factor de impacto:
Q1
Doi:
RSV—Still More Questions Than Answers
Louis Bont, Eugenio Baraldi, Brigitte Fauroux, Anne Greenough, Terho Heikkinen, Paolo Manzoni, Federico Martinón-Torres, Harish Nair and Nikolaos G. Papadopoulos, on behalf of ReSViNET
Doi:
Pediatr Infect Dis J.
Factor de impacto:
Q2
Doi:
Prognostic markers of meningococcal disease in children: recent advances and future challenges.
María Montero-Martín, David P Inwald, Enitan D Carrol & Federico Martinón-Torres
Doi:
Expert Rev Infect Ther
Factor de impacto:
Q1
Doi:
Pneumococcal Vaccination in Europe: Schedule Adherence
Alain Gervaix; Filippo Ansaldi; Antonio Brito-Avô; Chiara Azzari, Markus Knuf; Federico Martinón-Torres; David Tuerlinckx; Myint TinTin Htar, and George A. Syrogiannopoulos
Doi:
Clin Therap
Factor de impacto:
Q2
Doi:
Overuse of bronchodilators and steroids in bronchiolitis of different severity Bronchiolitis-study of variability, appropriateness, and adequacy
C. Ochoa Sangrador, J. González de Dios, Research Group of the aBREVIADo Project
Doi:
Allergol Immunopathol (Madr)
Factor de impacto:
Q3
Doi:
Caracterización microbiológica de las gastroenteritis agudas virales atendidas en un servicio de pediatría en un área de alta cobertura vacunal frente a rotavirus
Carlos García-Magán, María José de Castro-López, José Llovo-Taboada, Carmen Curros-Novo, Miriam Puente-Puig, Alicia Sánchez-Fauquier, Federico Martinón-Torres
Doi:
Enferm Infecc Microbiol Clin
Factor de impacto:
Q3
Doi:
Evolving Role of 13-valent Pneumococcal Conjugate Vaccine in Clinical Practice
Azzari C, Martinón-Torres F, Schmitt HJ, Dagan R.
Doi:
Pediatr Infect Dis J.
Factor de impacto:
Q2
Doi:
SIMULTANEOUS VIRAL WHOLE-GENOME SEQUENCING AND DIFFERENTIAL EXPRESSION PROFILING IN RESPIRATORY SYNCYTIAL VIRUS INFECTION OF INFANTS
Gu-Lung Lin, Tanya Golubchik, Simon Drysdale, Daniel O’Connor, Kimberley Jefferies, Anthony Brown, Mariateresa de Cesare, David Bonsall, M. Azim Ansari, Jeroen Aerssens, Louis Bont, Peter Openshaw, Federico Martinón-Torres, Rory Bowden, and Andrew J. Pollard; the RESCEU Investigators
The Journal of Infectious Diseases
Factor de impacto:
Q1
Doi:
IDENTIFICATION OF NOVEL RISK LOCI AND CAUSAL INSIGHTS FOR SPORADIC CREUTZFELDT-JAKOB DISEASE: A GENOME-WIDE ASSOCIATION STUDY
Emma Jones, Holger Hummerich, Emmanuelle Viré, James Uphill, Athanasios Dimitriadis, Helen Speedy, Tracy Campbell, Penny Norsworthy, Liam Quinn, Jerome Whitfield, Jacqueline Linehan, Zane Jaunmuktane, Sebastian Brandner, Parmjit Jat, Akin Nihat, Tze How Mok, Parvin Ahmed, Steven Collins, Christiane Stehmann, Shannon Sarros, Gabor G Kovacs, Michael D Geschwind, Aili Golubjatnikov, Karl Frontzek, Herbert Budka, Adriano Aguzzi, Hata Karamujić-Čomić, Sven J van der Lee, Carla A Ibrahim-Verbaas, Cornelia M Van Duijn, Beata Sikorska, Ewa Golanska, Pawel Liberski, Miguel Calero, Olga Calero, Pascual Sanchez-Juan, Antonio Salas, Federico Martinón-Torres, Elodie Bouaziz-Amar, Stephane Haik, Jean-Louis Laplanche, Jean-Phillipe Brandel, Phillipe Amouyel, Jean-Charles Lambert, Piero Parchi, Anna Bartoletti-Stella, Sabina Capellari, Anna Poleggi, Anna Ladogana, Maurizio Pocchiari, Serena Aneli, Giuseppe Matullo, Richard Knight, Saima Zafar, Inga Zerr, Stephanie Booth, Michael B Coulthart, Gerard H Jansen, Katie Glisic, Janis Blevins, Pierluigi Gambetti, Jiri Safar, Brian Appleby, John Collinge, Simon Mead
Factor de impacto:
Doi:
SEROPREVALENCE OF SARS-COV-2 AMONG PEDIATRIC HEALTHCARE WORKERS IN SPAIN
Ana Dacosta-Urbieta, Irene Rivero-Calle, Jacobo Pardo-Seco, Lorenzo Redondo-Collazo, Antonio Salas, Jose Gómez-Rial and Federico Martinón-Torres
Factor de impacto:
Doi:
ROLE OF MONOCYTES/MACROPHAGES IN COVID-19 PATHOGENESIS: IMPLICATIONS FOR THERAPY.
Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F.
Factor de impacto:
Doi:
RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU) BIRTH COHORT STUDY: DEFINING THE BURDEN OF INFANT RESPIRATORY SYNCYTIAL VIRUS DISEASE IN EUROPE
Joanne G Wildenbeest, Roy P Zuurbier, Koos Korten, Marlies A van Houten, Marie N Billard, Nicole Derksen-Lazet, Matthew D Snape, Simon B Drysdale, Hannah Robinson, Andrew J Pollard, Terho Heikkinen, Steve Cunningham, Amanda Leach, Federico Martinón-Torres, Carmen Rodríguez-Tenreiro Sánchez, Alberto Gómez-Carballa, Louis J Bont, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
Factor de impacto:
Doi:
PRESUMED RISK FACTORS AND BIOMARKERS FOR SEVERE RESPIRATORY SYNCYTIAL VIRUS DISEASE AND RELATED SEQUELAE: PROTOCOL FOR AN OBSERVATIONAL MULTICENTER, CASE-CONTROL STUDY FROM THE RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU)
Kimberley Jefferies, Simon B Drysdale, Hannah Robinson, Elizabeth Ann Clutterbuck, Luke Blackwell, Joseph McGinley, Gu-Lung Lin, Ushma Galal, Harish Nair, Jeroen Aerssens, Deniz Öner, Annefleur Langedijk, Louis Bont, Joanne G Wildenbeest, Federico Martinon-Torres, Carmen Rodríguez-Tenreiro Sánchez, Simon Nadel, Peter Openshaw, Ryan Thwaites, Myra Widjojoatmodjo, Linong Zhang, Thi Lien-Anh Nguyen, Carlo Giaquinto, Giuseppe Giordano, Eugenio Baraldi, Andrew J Pollard, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
Factor de impacto:
Doi:
BIOMARKERS FOR DISEASE SEVERITY IN CHILDREN INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS: A SYSTEMATIC LITERATURE REVIEW
Öner D, Drysdale SB, McPherson C, Lin GL, Janet S, Broad J, Pollard AJ, Aerssens J; RESCEU Investigators (F Martinón-Torres)
Factor de impacto:
Doi:
BIOMARKERS FOR THE DISCRIMINATION OF ACUTE KAWASAKI DISEASE FROM INFECTIONS IN CHILDHOOD
Judith Zandstra, Annemarie van de Geer, Michael W T Tanck, Diana van Stijn-Bringas, Dimitriades, Cathelijn E M Aarts, Sanne M Dietz, Robin van Bruggen, Nina A Schweintzger, Werner Zenz, Marieke Emonts, Dace Zavadska, Marko Pokorn, Effua Usuf, Henriette A Moll, Luregn J Schlapbach, Enitan D Carrol, Stephane Paulus, Maria Tsolia, Colin Fink, Shunmay Yeung, Chisato Shimizu, Adriana Tremoulet, Rachel Galassini, Victoria J Wright, Federico Martinón-Torres, Jethro Herberg, Jane Burns, Michael Levin, Taco W Kuijpers, EUCLIDS Consortium, PERFORM Consortium and UK Kawasaki Disease Genetics Study Network
Factor de impacto:
Doi:
SINGLE-DOSE NIRSEVIMAB FOR PREVENTION OF RSV IN PRETERM INFANTS
M. Pamela Griffin, Yuan Yuan, Therese Takas, Joseph B. Domachowske, Shabir A. Madhi, Paolo Manzoni, Eric A.F. Simões, Mark T. Esser, Anis A. Khan, Filip Dubovsky, Tonya Villafana and John P. DeVincenzo for the Nirsevimab Study Group*(Federico Martinón Torres)
Factor de impacto:
Doi:
RESPIRATORY SYNCYTIAL VIRUS VACCINATION DURING PREGNANCY AND EFFECTS IN INFANTS
S.A. Madhi, F.P. Polack, P.A. Piedra, F.M. Munoz, A.A. Trenholme, E.A.F. Simões, G.K. Swamy, S. Agrawal, K. Ahmed, A. August, A.H. Baqui, A. Calvert, J. Chen, I. Cho, M.F. Cotton, C.L. Cutland, J.A. Englund, A. Fix, B. Gonik, L. Hammitt, P.T. Heath, J.N. de Jesus, C.E. Jones, A. Khalil, D.W. Kimberlin, R. Libster, C.J. Llapur, M. Lucero, G. Pérez Marc, H.S. Marshall, M.S. Masenya,F. Martinón‐Torres, J.K. Meece, T.M. Nolan, A. Osman, K.P. Perrett, J.S. Plested, P.C. Richmond, M.D. Snape, J.H. Shakib, V. Shinde, T. Stoney, D.N. Thomas, A.T. Tita, M.W. Varner, M. Vatish, K. Vrbicky, J. Wen, K. Zaman, H.J. Zar, G.M. Glenn, and L.F. Fries, for the Prepare Study Group*
Factor de impacto:
Doi:
Links
Department of pediatricsGenCovidNanostringNextSeq
Legal noticePrivacy policy
Genvip 2023® – All rights reserved